NOT-DA-16-005: Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)

Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)

Notice Number: NOT-DA-16-005

Key Dates
Release Date: December 2, 2015
Estimated Publication Date of Announcement: January 2016
First Estimated Application Due Date: February 5, 2016
Earliest Estimated Award Date: September 2016
Earliest Estimated Start Date: November 2016

Related Announcements
PAR-13-080

Issued by
National Institute on Drug Abuse (NIDA)
National Cancer Institute (NCI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Purpose

The National Institute on Drug Abuse, with other NIH Institutes and Centers (ICs) the National Cancer Institute and The National Institute of Alcohol Abuse and Alcoholism, intend to reissue a Funding Opportunity Announcement (FOA) to solicit applications for research proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.

The FOA is expected to be published in January 2016 with an expected application due date in February 2016.

This FOA will utilize the R01 activity code. Details of the planned FOA are provided below.

Research Initiative Details

This Notice encourages investigators with expertise in the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of drug using behaviors and their consequences, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of drug abuse and HIV to begin to consider applying for this new FOA.

APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.

Inquiries

Please direct all inquiries to:

Marsha F. Lopez, Ph.D., M.H.S
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-1846
Email: lopezmar@nida.nih.gov